PRECINCT Network

The mission of the Pre-medical Cancer Immunotherapy Network for Canine Trials (PRECINCT), supported by grants from the National Cancer Institute, is to provide infrastructure and oversight to a highly collaborative and interactive network of researchers and clinician scientists working to accelerate the application of next generation immunotherapies through comparative oncology.